サマリー

呼吸器系のΒ2受容体を刺激することにより、アデニル酸シクラーゼが活性化され、細胞内の環状アデノシン一リン酸（Camp）の含有量を増加させ、遊離Ca2+を減少させることにより、気管支平滑筋を弛緩させ、アレルギー反応メディエーターの放出を抑制し、繊毛運動を促進し、血管透過性を低下させる、抗喘息剤。

市場分析と洞察。アドレナリン受容体アゴニストの世界および日本の市場について
本レポートでは、世界と日本のBeta Adrenergic Receptor Agonist市場に焦点を当てています。
2020年のBeta Adrenergic Receptor Agonistの世界市場規模はXX百万米ドルで、2021年から2027年の間にXX％のCAGRで、2027年末にはXX百万米ドルに達すると予想されています。日本では、Beta Adrenergic Receptor Agonistの市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX％のCAGRで成長すると予想されています。

世界のBeta Adrenergic Receptor Agonistの範囲と市場規模
Beta Adrenergic Receptor Agonist市場は、地域（国）別、プレイヤー別、タイプ別、アプリケーション別に分類されます。世界のBeta Adrenergic Receptor Agonist市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、地域（国）別、タイプ別、アプリケーション別に、2016年から2027年までの収益と予測に焦点を当てています。
日本市場については、2016-2027年のBeta Adrenergic Receptor Agonistの市場規模を、プレイヤー別、タイプ別、アプリケーション別に分析しています。主要プレイヤーには、日本で重要な役割を果たしているグローバルプレイヤーとローカルプレイヤーが含まれています。

タイプ別セグメント
非選択的βアドレナリン受容体アゴニスト
選択的β2アドレナリン受容体アゴニスト

用途別セグメント
気管支喘息
気管支炎

地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
U.K.
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
中国 台湾
インドネシア
タイ
マレーシア
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
UAE

会社別
シグマ-アルドリッチ
Med Chem Express Llc
Selleck
ジョンソン
ロシュ
ファイザー
ノバルティス
グラクソ・スミスクライン（GlaxoSmithKline
サノフィ
ギリアド・サイエンシズ

ページTOPに戻る

目次

1 Study Coverage
1.1 Beta Adrenergic Receptor Agonist Product Introduction
1.2 Market by Type
1.2.1 Global Beta Adrenergic Receptor Agonist Market Size Growth Rate by Type
1.2.2 Non-selective Beta Adrenergic Receptor Agonist
1.2.3 Selective β2 Adrenergic Receptor Agonist
1.3 Market by Application
1.3.1 Global Beta Adrenergic Receptor Agonist Market Size Growth Rate by Application
1.3.2 Asthma
1.3.3 Bronchitis
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Beta Adrenergic Receptor Agonist Market Size, Estimates and Forecasts
2.1.1 Global Beta Adrenergic Receptor Agonist Revenue 2016-2027
2.1.2 Global Beta Adrenergic Receptor Agonist Sales 2016-2027
2.2 Global Beta Adrenergic Receptor Agonist, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Beta Adrenergic Receptor Agonist Historical Market Size by Region (2016-2021)
2.3.1 Global Beta Adrenergic Receptor Agonist Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Beta Adrenergic Receptor Agonist Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Beta Adrenergic Receptor Agonist Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Beta Adrenergic Receptor Agonist Sales Forecast by Region (2022-2027)
2.4.2 Global Beta Adrenergic Receptor Agonist Revenue Forecast by Region (2022-2027)

3 Global Beta Adrenergic Receptor Agonist Competitor Landscape by Players
3.1 Global Top Beta Adrenergic Receptor Agonist Manufacturers by Sales
3.1.1 Global Beta Adrenergic Receptor Agonist Sales by Manufacturer (2016-2021)
3.1.2 Global Beta Adrenergic Receptor Agonist Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Beta Adrenergic Receptor Agonist Manufacturers by Revenue
3.2.1 Key Beta Adrenergic Receptor Agonist Manufacturers Covered: Ranking by Revenue
3.2.2 Global Beta Adrenergic Receptor Agonist Revenue by Manufacturers (2016-2021)
3.2.3 Global Beta Adrenergic Receptor Agonist Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Beta Adrenergic Receptor Agonist Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Beta Adrenergic Receptor Agonist Revenue in 2020
3.2.6 Global Beta Adrenergic Receptor Agonist Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Beta Adrenergic Receptor Agonist Price by Manufacturers
3.4 Global Beta Adrenergic Receptor Agonist Manufacturing Base Distribution, Product Types
3.4.1 Beta Adrenergic Receptor Agonist Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Beta Adrenergic Receptor Agonist Product Type
3.4.3 Date of International Manufacturers Enter into Beta Adrenergic Receptor Agonist Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Beta Adrenergic Receptor Agonist Market Size by Type (2016-2021)
4.1.1 Global Beta Adrenergic Receptor Agonist Sales by Type (2016-2021)
4.1.2 Global Beta Adrenergic Receptor Agonist Revenue by Type (2016-2021)
4.1.3 Beta Adrenergic Receptor Agonist Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Beta Adrenergic Receptor Agonist Market Size Forecast by Type (2022-2027)
4.2.1 Global Beta Adrenergic Receptor Agonist Sales Forecast by Type (2022-2027)
4.2.2 Global Beta Adrenergic Receptor Agonist Revenue Forecast by Type (2022-2027)
4.2.3 Beta Adrenergic Receptor Agonist Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Beta Adrenergic Receptor Agonist Market Size by Application (2016-2021)
5.1.1 Global Beta Adrenergic Receptor Agonist Sales by Application (2016-2021)
5.1.2 Global Beta Adrenergic Receptor Agonist Revenue by Application (2016-2021)
5.1.3 Beta Adrenergic Receptor Agonist Price by Application (2016-2021)
5.2 Beta Adrenergic Receptor Agonist Market Size Forecast by Application (2022-2027)
5.2.1 Global Beta Adrenergic Receptor Agonist Sales Forecast by Application (2022-2027)
5.2.2 Global Beta Adrenergic Receptor Agonist Revenue Forecast by Application (2022-2027)
5.2.3 Global Beta Adrenergic Receptor Agonist Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
6.1 Japan Beta Adrenergic Receptor Agonist Market Size YoY Growth 2016-2027
6.1.1 Japan Beta Adrenergic Receptor Agonist Sales YoY Growth 2016-2027
6.1.2 Japan Beta Adrenergic Receptor Agonist Revenue YoY Growth 2016-2027
6.1.3 Japan Beta Adrenergic Receptor Agonist Market Share in Global Market 2016-2027
6.2 Japan Beta Adrenergic Receptor Agonist Market Size by Players (International and Local Players)
6.2.1 Japan Top Beta Adrenergic Receptor Agonist Players by Sales (2016-2021)
6.2.2 Japan Top Beta Adrenergic Receptor Agonist Players by Revenue (2016-2021)
6.3 Japan Beta Adrenergic Receptor Agonist Historic Market Review by Type (2016-2021)
6.3.1 Japan Beta Adrenergic Receptor Agonist Sales Market Share by Type (2016-2021)
6.3.2 Japan Beta Adrenergic Receptor Agonist Revenue Market Share by Type (2016-2021)
6.3.3 Japan Beta Adrenergic Receptor Agonist Price by Type (2016-2021)
6.4 Japan Beta Adrenergic Receptor Agonist Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Beta Adrenergic Receptor Agonist Sales Forecast by Type (2022-2027)
6.4.2 Japan Beta Adrenergic Receptor Agonist Revenue Forecast by Type (2022-2027)
6.4.3 Japan Beta Adrenergic Receptor Agonist Price Forecast by Type (2022-2027)
6.5 Japan Beta Adrenergic Receptor Agonist Historic Market Review by Application (2016-2021)
6.5.1 Japan Beta Adrenergic Receptor Agonist Sales Market Share by Application (2016-2021)
6.5.2 Japan Beta Adrenergic Receptor Agonist Revenue Market Share by Application (2016-2021)
6.5.3 Japan Beta Adrenergic Receptor Agonist Price by Application (2016-2021)
6.6 Japan Beta Adrenergic Receptor Agonist Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Beta Adrenergic Receptor Agonist Sales Forecast by Application (2022-2027)
6.6.2 Japan Beta Adrenergic Receptor Agonist Revenue Forecast by Application (2022-2027)
6.6.3 Japan Beta Adrenergic Receptor Agonist Price Forecast by Application (2022-2027)

7 North America
7.1 North America Beta Adrenergic Receptor Agonist Market Size YoY Growth 2016-2027
7.2 North America Beta Adrenergic Receptor Agonist Market Facts & Figures by Country
7.2.1 North America Beta Adrenergic Receptor Agonist Sales by Country (2016-2021)
7.2.2 North America Beta Adrenergic Receptor Agonist Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Beta Adrenergic Receptor Agonist Market Size YoY Growth 2016-2027
8.2 Asia Pacific Beta Adrenergic Receptor Agonist Market Facts & Figures by Region
8.2.1 Asia Pacific Beta Adrenergic Receptor Agonist Sales by Region (2016-2021)
8.2.2 Asia Pacific Beta Adrenergic Receptor Agonist Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia

9 Europe
9.1 Europe Beta Adrenergic Receptor Agonist Market Size YoY Growth 2016-2027
9.2 Europe Beta Adrenergic Receptor Agonist Market Facts & Figures by Country
9.2.1 Europe Beta Adrenergic Receptor Agonist Sales by Country (2016-2021)
9.2.2 Europe Beta Adrenergic Receptor Agonist Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Beta Adrenergic Receptor Agonist Market Size YoY Growth 2016-2027
10.2 Latin America Beta Adrenergic Receptor Agonist Market Facts & Figures by Country
10.2.1 Latin America Beta Adrenergic Receptor Agonist Sales by Country (2016-2021)
10.2.2 Latin America Beta Adrenergic Receptor Agonist Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Beta Adrenergic Receptor Agonist Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Beta Adrenergic Receptor Agonist Market Facts & Figures by Country
11.2.1 Middle East and Africa Beta Adrenergic Receptor Agonist Sales by Country (2016-2021)
11.2.2 Middle East and Africa Beta Adrenergic Receptor Agonist Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Sigma-Aldrich
12.1.1 Sigma-Aldrich Corporation Information
12.1.2 Sigma-Aldrich Description and Business Overview
12.1.3 Sigma-Aldrich Beta Adrenergic Receptor Agonist Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Sigma-Aldrich Beta Adrenergic Receptor Agonist Products Offered
12.1.5 Sigma-Aldrich Recent Development
12.2 Med Chem Express Llc
12.2.1 Med Chem Express Llc Corporation Information
12.2.2 Med Chem Express Llc Description and Business Overview
12.2.3 Med Chem Express Llc Beta Adrenergic Receptor Agonist Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Med Chem Express Llc Beta Adrenergic Receptor Agonist Products Offered
12.2.5 Med Chem Express Llc Recent Development
12.3 Selleck
12.3.1 Selleck Corporation Information
12.3.2 Selleck Description and Business Overview
12.3.3 Selleck Beta Adrenergic Receptor Agonist Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Selleck Beta Adrenergic Receptor Agonist Products Offered
12.3.5 Selleck Recent Development
12.4 Johnson
12.4.1 Johnson Corporation Information
12.4.2 Johnson Description and Business Overview
12.4.3 Johnson Beta Adrenergic Receptor Agonist Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Johnson Beta Adrenergic Receptor Agonist Products Offered
12.4.5 Johnson Recent Development
12.5 Roche
12.5.1 Roche Corporation Information
12.5.2 Roche Description and Business Overview
12.5.3 Roche Beta Adrenergic Receptor Agonist Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Roche Beta Adrenergic Receptor Agonist Products Offered
12.5.5 Roche Recent Development
12.6 Pfizer
12.6.1 Pfizer Corporation Information
12.6.2 Pfizer Description and Business Overview
12.6.3 Pfizer Beta Adrenergic Receptor Agonist Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Pfizer Beta Adrenergic Receptor Agonist Products Offered
12.6.5 Pfizer Recent Development
12.7 Novartis
12.7.1 Novartis Corporation Information
12.7.2 Novartis Description and Business Overview
12.7.3 Novartis Beta Adrenergic Receptor Agonist Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Novartis Beta Adrenergic Receptor Agonist Products Offered
12.7.5 Novartis Recent Development
12.8 GlaxoSmithKline
12.8.1 GlaxoSmithKline Corporation Information
12.8.2 GlaxoSmithKline Description and Business Overview
12.8.3 GlaxoSmithKline Beta Adrenergic Receptor Agonist Sales, Revenue and Gross Margin (2016-2021)
12.8.4 GlaxoSmithKline Beta Adrenergic Receptor Agonist Products Offered
12.8.5 GlaxoSmithKline Recent Development
12.9 Sanofi
12.9.1 Sanofi Corporation Information
12.9.2 Sanofi Description and Business Overview
12.9.3 Sanofi Beta Adrenergic Receptor Agonist Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Sanofi Beta Adrenergic Receptor Agonist Products Offered
12.9.5 Sanofi Recent Development
12.10 Gilead Sciences
12.10.1 Gilead Sciences Corporation Information
12.10.2 Gilead Sciences Description and Business Overview
12.10.3 Gilead Sciences Beta Adrenergic Receptor Agonist Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Gilead Sciences Beta Adrenergic Receptor Agonist Products Offered
12.10.5 Gilead Sciences Recent Development
12.11 Sigma-Aldrich
12.11.1 Sigma-Aldrich Corporation Information
12.11.2 Sigma-Aldrich Description and Business Overview
12.11.3 Sigma-Aldrich Beta Adrenergic Receptor Agonist Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Sigma-Aldrich Beta Adrenergic Receptor Agonist Products Offered
12.11.5 Sigma-Aldrich Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Beta Adrenergic Receptor Agonist Industry Trends
13.2 Beta Adrenergic Receptor Agonist Market Drivers
13.3 Beta Adrenergic Receptor Agonist Market Challenges
13.4 Beta Adrenergic Receptor Agonist Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Beta Adrenergic Receptor Agonist Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer